The hypereosinophilic syndrome and the biology of cancer.
Schwartz
Robert S
RS
D001549:Benzamides; D002872:Chromosome Deletion; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004802:Eosinophilia; D004804:Eosinophils / Q000648:ultrastructure; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy / Q000235:genetics*; D000068877:Imatinib Mesylate; D009369:Neoplasms / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics; D011743:Pyrimidines / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000502:physiology; D014178:Translocation, Genetic
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases